DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Montemurro M, Domont J, Blesius A et al.
Dasatinib first-line treatment in gastrointestinal stromal tumors: A multicenter phase II trial of the SAKK (SAKK 56/07).
J Clin Oncol 2012;
30 abstr 10033
We do not assume any responsibility for the contents of the web pages of other providers.